The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis

BACKGROUND: The evidence of using JAK inhibitors among hospitalized patients with COVID-19 is conflicting. The systematic review and meta-analysis aimed to address the efficacy of Janus Kinase (JAK) Inhibitors in reducing risk of mortality among hospitalized patients with COVID-19. METHODS: Several...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Epidemiol Glob Health
Autors principals: Wijaya, Indra, Andhika, Rizky, Huang, Ian, Purwiga, Aga, Budiman, Kevin Yonatan, Bashari, Muhammad Hasan, Reniarti, Lelani, Roesli, Rully Marsis Amirullah
Format: Artigo
Idioma:Inglês
Publicat: The Authors. Published by Elsevier B.V. on behalf of INDIACLEN. 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088409/
https://ncbi.nlm.nih.gov/pubmed/33969237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cegh.2021.100755
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars